NEOGEN CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.31 USD | +4.50% |
|
+1.23% | -38.79% |
| Apr. 18 | Neogen Corporation Forms Genomics Relationship with Performance Food Group | CI |
| Apr. 15 | Piper Sandler Adjusts Price Target on Neogen to $17 From $19, Maintains Neutral Rating | MT |
Chart calendar Neogen Corporation
9924a439d6266277ee32dab1eac91475.34I1XfaQEriq-5Z9B4J0wxqSVE5bpYlZE3qHfVnlNbQ.lOh6O8DRX4ntyK8KWLsAtSjhZxoa0scIWin-LGGwDcW90lYuxsVB28-tzw~9588c73aea12877e253b480935542a16
Upcoming events on Neogen Corporation
Past events on Neogen Corporation
| 2024-04-09 08:00 am | Q3 2024 Earnings Call |
| 2024-04-09 07:00 am | Q3 2024 Earnings Release |
| 2024-01-11 12:00 pm | JPMorgan Healthcare Conference |
| 2024-01-09 08:00 am | Q2 2024 Earnings Call |
| 2024-01-09 07:00 am | Q2 2024 Earnings Release |
| 2023-11-30 01:30 pm | Piper Sandler Healthcare Conference |
| 2023-10-25 10:00 am | Annual General Meeting |
| 2023-10-10 08:00 am | Q1 2024 Earnings Call |
| 2023-10-10 07:00 am | Q1 2024 Earnings Release |
| 2023-09-07 10:15 am | Wells Fargo Healthcare Conference |
| 2023-07-27 08:00 am | Q4 2023 Earnings Call |
| 2023-07-27 07:00 am | Q4 2023 Earnings Release |
| 2023-06-06 05:00 pm | William Blair Growth Stock Conference |
| 2023-03-30 08:00 am | Q3 2023 Earnings Call |
| 2023-03-30 07:00 am | Q3 2023 Earnings Release |
| 2023-01-11 11:15 am | JP Morgan Healthcare Conference |
| 2023-01-05 08:00 am | Interim 2023 Earnings Call |
| 2023-01-05 07:00 am | Interim 2023 Earnings Release |
| 2022-11-30 08:00 am | Piper Sandler Healthcare Conference |
| 2022-10-05 | Annual General Meeting |
Annual results
| Fiscal Period | May | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 414 415 -0.09% | 418 421 -0.73% | 468 460 1.91% | 527 525 0.33% | 822 808 1.75% | 912 |
|
EBITDA Million USD | Released Forecast Spread | 85,7 86,5 -0.85% | 85,9 86,7 -0.88% | 95,2 95,1 0.07% | 82,3 103 -20.4% | 205 195 5.3% | 212 |
|
EBIT Million USD | Released Forecast Spread | 68,1 68,1 -0% | 67,5 65,9 2.45% | 74,2 75,3 -1.51% | 58,6 70,6 -17.01% | 37,5 23,1 62.42% | 57,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 73,0 73,1 -0.21% | 72,3 70,7 2.27% | 75,3 79,0 -4.74% | 60,2 71,3 -15.55% | -22,0 -38,8 43.14% | -13,0 |
|
Net income Million USD | Released Forecast Spread | 60,2 59,8 0.58% | 59,5 59,1 0.62% | 60,9 64,8 -5.99% | 48,3 57,5 -15.93% | -22,9 -35,6 35.79% | -8,08 |
|
EPS USD | Released Forecast Spread | 0,58 0,57 1.23% | 0,57 0,56 1.19% | 0,57 0,61 -6.04% | 0,45 0,54 -15.89% | -0,12 -0,14 14.29% | -0,04 |
| Announcement Date | 23/07/19 | 21/07/20 | 20/07/21 | 26/07/22 | 27/07/23 | - |
Quarterly results
| Fiscal Period | May | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 128 130 -1.35% | 140 138 1.25% | 132 136 -2.51% | 230 228 0.76% | 218 219 -0.28% | 242 228 6.19% | 229 231 -0.92% | 230 233 -1.39% | 229 230 -0.52% | 225 | 229 | 234 | 238 | 237 |
|
EBITDA Million USD | Released Forecast Spread | 12,7 24,8 -48.85% | 23,9 26,1 -8.63% | 25,5 27,8 -8.3% | 64,1 60,2 6.4% | 51,3 53,7 -4.53% | 63,1 52,9 19.34% | 52,4 55,7 -5.96% | 55,1 57,2 -3.7% | 52,7 60,0 -12.14% | 51,4 | 56,0 | 58,0 | 57,0 | 56,0 |
|
EBIT Million USD | Released Forecast Spread | 17,0 19,5 -12.93% | 18,0 20,1 -10.26% | 19,8 18,5 6.95% | -7,66 -9,00 14.93% | 15,7 10,4 51.2% | 23,4 9,00 160.22% | 19,1 20,9 -8.5% | 14,5 21,1 -31.56% | 12,0 21,2 -43.24% | 12,1 | 16,4 | 16,6 | 14,3 | 12,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 18,9 20,2 -6.6% | 6,66 16,7 -60.13% | -34,1 -21,6 -57.83% | -2,26 -4,39 48.5% | 7,65 -9,12 183.86% | 1,66 7,05 -76.42% | -3,75 6,15 -160.97% | -5,82 4,75 -222.62% | -5,13 | -0,60 | -1,10 | -3,00 | -3,90 | |
|
Net income Million USD | Released Forecast Spread | 15,0 16,6 -9.72% | 5,21 13,2 -60.54% | -41,8 -17,1 -144.68% | 8,19 -3,43 338.71% | 5,57 -7,20 177.42% | 1,50 5,56 -72.97% | -3,49 4,85 -171.95% | -2,02 3,80 -153.23% | -4,07 | -0,50 | -0,80 | -2,40 | -3,10 | |
|
EPS USD | Released Forecast Spread | 0,14 0,16 -9.68% | 0,05 0,12 -58.33% | -0,19 -0,08 -137.5% | 0,04 -0,02 366.67% | 0,03 -0,04 185.71% | 0,01 0,03 -60% | -0,02 0,03 -180% | -0,01 0,02 -166.67% | -0,02 | 0,00 | 0,00 | -0,01 | -0,01 | |
| Announcement Date | 24/03/22 | 26/07/22 | 27/09/22 | 05/01/23 | 30/03/23 | 27/07/23 | 10/10/23 | 09/01/24 | 09/04/24 | - | - | - | - | - |
| Today 04:00 pm | ALIGN TECHNOLOGY, INC.: Q1 2024 Earnings Release |
| Today 04:05 pm | CONMED CORPORATION: Q1 2024 Earnings Release |
| 2024-04-24 | DEXCOM, INC.: Q1 2024 Earnings Release |
| 2024-04-25 06:00 am | WEST PHARMACEUTICAL SERVICES, INC.: Q1 2024 Earnings Release |
| 2024-04-25 | MOTIC (XIAMEN) ELECTRIC GROUP CO.,LTD: Q1 2024 Earnings Release |
| 2024-04-25 | MICRO-TECH (NANJING) CO.,LTD: Q1 2024 Earnings Release |
| 2024-04-25 | SINOCARE INC.: Q4 2023 Earnings Release |
| 2024-04-25 | SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-25 | JAFRON BIOMEDICAL CO.,LTD.: Q1 2024 Earnings Release |
| 2024-04-25 | AVANTOR, INC.: Q1 2024 Earnings Release |
Past sector events for Neogen Corporation
| Today 01:30 am | XVIVO PERFUSION AB: Q1 2024 Earnings Release |
| Today | SHANGHAI KINETIC MEDICAL CO., LTD: Q1 2024 Earnings Release |
| 2024-04-21 | SHANGHAI KINETIC MEDICAL CO., LTD: Q4 2023 Earnings Release |
| 2024-04-19 | LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-19 | LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-18 | WELL LEAD MEDICAL CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-18 08:00 am | ARJO AB: Q1 2024 Earnings Release |
| 2024-04-18 01:02 am | SARTORIUS STEDIM BIOTECH: Q1 2024 Earnings Release |
| 2024-04-17 07:30 am | ABBOTT LABORATORIES: Q1 2024 Earnings Release |
| 2024-04-16 | JIANGXI SANXIN MEDTEC CO.,LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NEOG Stock
- Calendar Neogen Corporation
